Eleanor Holmes Norton actually said...
Is there any conceivable justification for a company that had nothing to do with the R&D, taking over a company, and then overnight raising the price so that it is, let's be fair, out of reach for patients and even some hospitals?
Context
Questioning the justification for a drastic price increase on Daraprim after its acquisition.
02/03/2016